Skip to main content
HR 4065 117th Congress House Health Administrative law and regulatory procedures Congressional oversight Department of Health and Human Services Digestive and metabolic diseases Drug therapy Government studies and investigations Health care costs and insurance Health care coverage and access Health care quality Health facilities and institutions Health promotion and preventive care Health technology, devices, supplies Medicaid Medical research Medical tests and diagnostic methods Medicare Minority health Organ and tissue donation and transplantation State and local government operations

Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

Introduced: June 22, 2021 Introduced by: Sewell, Terri A. Democratic · Alabama See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 23, 2021
Referred to the Subcommittee on Health.
Jun 22, 2021
Referred to the Subcommittee on Health.
Jun 22, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 22, 2021
Introduced in House
 Plain-English summary Congressional Research Service

Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

This bill modifies provisions relating to Medicare coverage of treatments for chronic kidney disease.

Specifically, the bill expands the Medicare annual wellness visit to include chronic kidney disease screening and allows certain Medicare beneficiaries who have End Stage Renal Disease (ESRD) to enroll in Medicare supplemental policies. It also (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services.

The bill also extends the coordination period (from 30 months to 42 months) during which private health insurers may serve as the primary payers for Medicare beneficiaries with ESRD.

What's happening now June 23, 2021

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4
 Cosponsors 5
All 5 Democratic 3 Republican 2